News (I4M)
Enfants sans Cancer race 2024: a historic 13th edition
Enfants sans Cancer race 2024: a historic 13th edition
An extraORdinary mobilization to conclude September in Gold 2024 As every year for the past 13 years, the last weekend of September is dedicated to the major charity race Enfants sans Cancer for our association. On Sunday, September 29, 2024, at the Domaine National de Saint-Cloud and remotely, from Montreal to Marseille, across all of Europe, […]What is a nephroblastoma?
What is a nephroblastoma?
Nephroblastoma, also known as Wilms’ tumor, is the most common kidney cancer in children. It accounts for between 5% and 14% of all childhood cancers (1 case per 10,000 births, with nearly a hundred cases per year on average in France). Wilms’ tumor usually appears in children under 5 years old, but it can sometimes […]What is an osteosarcoma?
What is an osteosarcoma?
Osteosarcoma is the most common malignant bone tumor in adolescents and young adults (100 to 150 new patients per year in France). The majority of these osteosarcomas (70%) occur in young people aged 10 to 25 years, and it affects boys more frequently (1 girl affected for every 1.4 boys). Localized osteosarcomas are limited to […]Imagine for Margo at ASCO!
Imagine for Margo at ASCO!
Imagine for Margo was at ASCO 2024! We are incredibly proud to have been invited by the American Society of Clinical Oncology (ASCO) and to have had a stand for the very first time at this major international oncology congress! This is a great recognition for our association, which was the only representative of pediatric […]CHILDREN WITHOUT CANCER CITY 2024: A NEW MOBILIZATION RECORD
CHILDREN WITHOUT CANCER CITY 2024: A NEW MOBILIZATION RECORD
Children Without Cancer City Race: A Day of Hope Against Pediatric Cancer On Thursday, May 30, 2024, the Children Without Cancer City race returned to La Défense, flooding the heart of Europe’s largest business district with an incredible wave of pink and blue. For a few hours, a sea of 2,000 runners and walkers, including […]SACHA: the program that secures access to medicines outside clinical trials
SACHA: the program that secures access to medicines outside clinical trials
Context of the SACHA Study France stands as a pioneer in Europe in the field of developing new drugs in pediatric oncology. For example, from 2015 to 2018, over 2,200 patients were enrolled in 34 clinical trials by ITCC (Innovative Therapies for Children with Cancer). Among them, 53% of the patients were recruited in France. […]PEDIATRIC CANCERS: TOGETHER, THERE IS HOPE!
PEDIATRIC CANCERS: TOGETHER, THERE IS HOPE!
Unity is strength ! Today, it is time to find a new model for financing therapeutic innovation for children and adolescents with cancer. In an article published in Le Quotidien du Médecin and Economie Matin, our President, Patricia Blanc, pleads in favor of major collective action, an association between solidarity and innovation to go even […]FIGHT KIDS CANCER 2024 LAUNCHES A CALL FOR EUROPEAN PROJECTS DEDICATED TO BRAIN TUMORS
